Concepedia

Kenji M. Fujihara

KM

15

Publications

463

Citations

13

H-Index

2018

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

St Vincent's Hospital Melbourne

APR Technologies (Sweden)

Victorian Clinical Genetics Services

Kenji M. Fujihara is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2023

15

Publications

15

Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

Kenji M. Fujihara, Bonnie Z. Zhang, Thomas D. Jackson et al. · Science Advances · 2022 · 79 citations · Full text

Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome

Yilin Kang, Alexander J. Anderson, Thomas D. Jackson et al. · eLife · 2019 · 50 citations · Full text

SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation Status

Kenji M. Fujihara, Mariana Corrales Benitez, Carlos S. Cabalag et al. · Molecular Cancer Therapeutics · 2021 · 44 citations · Full text

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death

Sophia Ceder, Sofi Eriksson, Emarndeena H. Cheteh et al. · EMBO Molecular Medicine · 2020 · 42 citations · Full text

The TIM22 complex mediates the import of sideroflexins and is required for efficient mitochondrial one-carbon metabolism

Thomas D. Jackson, Daniella H. Hock, Kenji M. Fujihara et al. · Molecular Biology of the Cell · 2021 · 35 citations · Full text

Rows per page

1–5 of 15